NCT00163358

Brief Summary

The aim of the study is to compare the efficacy of ciclesonide versus fixed combination of fluticasone propionate/salmeterol versus placebo, on long-term asthma control in patients with mild persistent asthma. The study duration consists of a baseline period (2 weeks) and a treatment period (12 months). The study will provide further data on safety and tolerability of ciclesonide.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
630

participants targeted

Target at P50-P75 for phase_3 asthma

Timeline
Completed

Started Sep 2003

Typical duration for phase_3 asthma

Geographic Reach
7 countries

111 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2003

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

September 12, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 14, 2005

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2005

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2005

Completed
Last Updated

November 30, 2016

Status Verified

October 1, 2016

Enrollment Period

2.1 years

First QC Date

September 12, 2005

Last Update Submit

November 29, 2016

Conditions

Keywords

AsthmaCiclesonideFluticasone propionateSalmeterol

Outcome Measures

Primary Outcomes (2)

  • time until the first severe asthma exacerbation occurs

  • number of poorly controlled asthma days.

Secondary Outcomes (14)

  • percentage of days with asthma control

  • percentage of days with asthma symptoms

  • percentage of nocturnal awakenings due to asthma

  • asthma symptom score

  • number of inhalations of rescue medication

  • +9 more secondary outcomes

Interventions

Eligibility Criteria

Age12 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of mild persistent asthma
  • Pre-treatment with SABAs only
  • FEV1 ≥80% predicted
  • Good health with the exception of asthma

You may not qualify if:

  • Concomitant severe diseases or diseases which are contraindications for the use of inhaled steroids
  • COPD (chronic bronchitis or emphysema) and/or other relevant lung diseases causing alternating impairment in pulmonary function
  • Pregnancy
  • Intention to become pregnant during the course of the study
  • Breast feeding
  • Lack of safe contraception
  • Current smokers ≥10 pack-years and ex-smokers with ≥10 pack-years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (111)

Altana Pharma/Nycomed

Adelaide South Australia, 5000, Australia

Location

Altana Pharma/Nycomed

Auchenflower, QLD 4066, Australia

Location

Altana Pharma/Nycomed

Bracken Ridge, QLD 4017, Australia

Location

Altana Pharma/Nycomed

Burwood, NSW 2134, Australia

Location

Altana Pharma/Nycomed

Camperdown, NSW 2050, Australia

Location

Altana Pharma/Nycomed

Carina Heights, QLD 4152, Australia

Location

Altana Pharma/Nycomed

Clayton, VIC 3168, Australia

Location

Altana Pharma/Nycomed

Concord, 2139, Australia

Location

Altana Pharma/Nycomed

Geelong, VIC 3220, Australia

Location

Altana Pharma/Nycomed

Inala, QLD 4077, Australia

Location

Altana Pharma/Nycomed

Kippa-Ring, QLD 4021, Australia

Location

Altana Pharma/Nycomed

Nedlands, WA 6009, Australia

Location

Altana Pharma/Nycomed

Rosebud, VIC 3939, Australia

Location

Altana Pharma/Nycomed

South Brisbane, QLD 4101, Australia

Location

Altana Pharma/Nycomed

Toorak Gardens, SA 5056, Australia

Location

Altana Pharma/Nycomed

Wayville, SA 5034, Australia

Location

Altana Pharma/Nycomed

Beaconsfield, QC, H9W2X3, Canada

Location

Altana Pharma/Nycomed

Coquitlam, V3K 3P4, Canada

Location

Altana Pharma/Nycomed

Coquitlam, BC, V3K 3V9, Canada

Location

Altana Pharma/Nycomed

Corner Brook, NFLD, Canada

Location

Altana Pharma/Nycomed

Cowansville, J2K2X9, Canada

Location

Altana Pharma/Nycomed

Kingston, Ontario, K7L 2V6, Canada

Location

Altana Pharma/Nycomed

Langley BC, V3A 4H9, Canada

Location

Altana Pharma/Nycomed

Laval, H7V3Y7, Canada

Location

Altana Pharma/Nycomed

Les Saules, QC, G1P 1J6, Canada

Location

Altana Pharma/Nycomed

Longueuil, PQ, J4N 1E1, Canada

Location

Altana Pharma/Nycomed

Montreal, H4J1C5, Canada

Location

Altana Pharma/Nycomed

Montreal, PQ, H3H 1V4, Canada

Location

Altana Pharma/Nycomed

North Bay, P1B2H3, Canada

Location

Altana Pharma/Nycomed

North York, M3H 3S3, Canada

Location

Altana Pharma/Nycomed

Ottawa, K1Y 4G2, Canada

Location

Altana Pharma/Nycomed

Penticton, BC, V2A 5C8, Canada

Location

Altana Pharma/Nycomed

Québec, G8T 7A1, Canada

Location

Altana Pharma/Nycomed

Saint John, E2K2T8, Canada

Location

Altana Pharma/Nycomed

Sainte-Foy, Quebec, G1V4G5, Canada

Location

Altana Pharma/Nycomed

Saskatoon, SK, S7K 3H3, Canada

Location

Altana Pharma/Nycomed

St. John's, A1A 3R5, Canada

Location

Altana Pharma/Nycomed

St. John's, A1E 2C2, Canada

Location

Altana Pharma/Nycomed

Ste-Foy PQ, G1V 4M6, Canada

Location

Altana Pharma/Nycomed

Toronto, M4N3N5, Canada

Location

Altana Pharma/Nycomed

Toronto, M4P1P2, Canada

Location

Altana Pharma/Nycomed

Toronto, M9W 4L6, Canada

Location

Altana Pharma/Nycomed

Toronto on, M5S 2A5, Canada

Location

Altana Pharma/Nycomed

Beroun, 266 01, Czechia

Location

Altana Pharma/Nycomed

Cvikov, 471 54, Czechia

Location

Altana Pharma/Nycomed

Česká Lípa, 470 01, Czechia

Location

Altana Pharma/Nycomed

Havlickuv, 580 01, Czechia

Location

Altana Pharma/Nycomed

Jihlava, 58601, Czechia

Location

Altana Pharma/Nycomed

Jindřichův Hradec, 377 01, Czechia

Location

Altana Pharma/Nycomed

Karlovy Vary, 360 00, Czechia

Location

Altana Pharma/Nycomed

Kladno, 272 01, Czechia

Location

Altana Pharma/Nycomed

Kutná Hora, 28401, Czechia

Location

Altana Pharma/Nycomed

Ostrava-Marián.Hory, 70030, Czechia

Location

Altana Pharma/Nycomed

Prague, 100 00, Czechia

Location

Altana Pharma/Nycomed

Prague, 128 00, Czechia

Location

Altana Pharma/Nycomed

Prague, 14046, Czechia

Location

Altana Pharma/Nycomed

Prague, 181 00, Czechia

Location

Altana Pharma/Nycomed

Prague, 190 61, Czechia

Location

Altana Pharma/Nycomed

Pribram VI, 261 05, Czechia

Location

Altana Pharma/Nycomed

Príbram VIII, 261 01, Czechia

Location

Altana Pharma/Nycomed

Rokycany, 337 01, Czechia

Location

Altana Pharma/Nycomed

Strakonice, 38601, Czechia

Location

Altana Pharma/Nycomed

Trutnov, 54101, Czechia

Location

Altana Pharma/Nycomed

Ústí nad Labem, 401 13, Czechia

Location

Altana Pharma/Nycomed

Budapest, 1046, Hungary

Location

Altana Pharma/Nycomed

Budapest, 1134, Hungary

Location

Altana Pharma/Nycomed

Budapest, 1529, Hungary

Location

Altana Pharma/Nycomed

Budapest XI, 1117, Hungary

Location

Altana Pharma/Nycomed

Budapet, 1529, Hungary

Location

Altana Pharma/Nycomed

Kecskemét, 6000, Hungary

Location

Altana Pharma/Nycomed

Nyíregyháza, 4400, Hungary

Location

Altana Pharma/Nycomed

Szarvas, 5540, Hungary

Location

Altana Pharma/Nycomed

Tatabánya, 2800, Hungary

Location

Altana Pharma/Nycomed

Bydgoszcz, 85-091, Poland

Location

Altana Pharma/Nycomed

Bydgoszcz, 85-681, Poland

Location

Altana Pharma/Nycomed

Lodz, 91-520, Poland

Location

Altana Pharma/Nycomed

Lódz', 90-153, Poland

Location

Altana Pharma/Nycomed

Rzeszów, 35-068, Poland

Location

Altana Pharma/Nycomed

Rzeszów, 35-302, Poland

Location

Altana Pharma/Nycomed

Warsaw, 01-138, Poland

Location

Altana Pharma/Nycomed

Wroclaw, 50-417, Poland

Location

Altana Pharma/Nycomed

Wroclaw, 53-674, Poland

Location

Altana Pharma/Nycomed

Arcadia, Pretoria, 132, South Africa

Location

Altana Pharma/Nycomed

Bellville, Cape Town, 7530, South Africa

Location

Altana Pharma/Nycomed

Berea, Durban, 4000, South Africa

Location

Altana Pharma/Nycomed

Bloemfontein, 9300, South Africa

Location

Altana Pharma/Nycomed

Bloemfontein, 9301, South Africa

Location

Altana Pharma/Nycomed

Cape Town, 7764, South Africa

Location

Altana Pharma/Nycomed

Centurion, Pretoria, 157, South Africa

Location

Altana Pharma/Nycomed

Daveyton, 1520, South Africa

Location

Altana Pharma/Nycomed

Durban, Amanzimtoti, 4126, South Africa

Location

Altana Pharma/Nycomed

George, 6539, South Africa

Location

Altana Pharma/Nycomed

Midrand, 1685, South Africa

Location

Altana Pharma/Nycomed

Mowbray, Cape Town, 7925, South Africa

Location

Altana Pharma/Nycomed

Paarl, 7646, South Africa

Location

Altana Pharma/Nycomed

Panorama / RSA-Cape Town, 7500, South Africa

Location

Altana Pharma/Nycomed

Pretoria, 186, South Africa

Location

Altana Pharma/Nycomed

Alcorcón (Madrid), 28922, Spain

Location

Altana Pharma/Nycomed

Alicante, 3001, Spain

Location

Altana Pharma/Nycomed

Alicante, 3540, Spain

Location

Altana Pharma/Nycomed

Barcelona, 8222, Spain

Location

Altana Pharma/Nycomed

Campdevanol (Girona), 17530, Spain

Location

Altana Pharma/Nycomed

Elda (Alicante), 3600, Spain

Location

Altana Pharma/Nycomed

Guadalajara, 19002, Spain

Location

Altana Pharma/Nycomed

Leganes (Madrid), 28914, Spain

Location

Altana Pharma/Nycomed

Palma de Mallorca, 7014, Spain

Location

Altana Pharma/Nycomed

Peralada (Girona), 17491, Spain

Location

Altana Pharma/Nycomed

Petrer (Alicante), 3610, Spain

Location

Altana Pharma/Nycomed

San Vicente Del Raspeig (Alicante), 3187, Spain

Location

Altana Pharma/Nycomed

Santiago de Compostela, 15706, Spain

Location

Altana Pharma/Nycomed

Valencia, 46017, Spain

Location

Related Publications (1)

  • Postma DS, O'Byrne PM, Pedersen S. Comparison of the effect of low-dose ciclesonide and fixed-dose fluticasone propionate and salmeterol combination on long-term asthma control. Chest. 2011 Feb;139(2):311-318. doi: 10.1378/chest.09-1735. Epub 2010 Nov 18.

Related Links

MeSH Terms

Conditions

Asthma

Interventions

ciclesonide

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • AstraZeneca AstraZeneca

    AstraZeneca

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 12, 2005

First Posted

September 14, 2005

Study Start

September 1, 2003

Primary Completion

October 1, 2005

Study Completion

October 1, 2005

Last Updated

November 30, 2016

Record last verified: 2016-10

Locations